Purchase Order HHSF223201510609A

This is a federal contract award from the Food and Drug Administration (FDA), a civilian agency, to Pharsight Corporation, a small business vendor. The contract, valued at $153,470.00, is for the "PHOENIX QUANTUM SOFTWARE BUNDLE" and has a firm fixed price. The contract was awarded on July 20, 2016, with a completion date of July 21, 2017. The place of performance is Rockville, Maryland. This contract appears to be a stand-alone purchase order and is not associated with a larger...

This is a $845,852.26 firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Certara USA Inc., a leading provider of biosimulation software and consulting services for the pharmaceutical industry. The contract is for the renewal of Certara's Phoenix Quantum software licenses and IVIVC Toolkits, which are essential for the FDA's Office of Clinical Pharmacology to analyze clinical pharmacology and pharmacometric data submitted by drug sponsors. The contract...

<p>This is a $75,000.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Patsnap PTE LTD, a foreign-owned for-profit organization, for access to the PATSNAP database. The contract has an ultimate completion date of July 2, 2020 and was awarded on July 3, 2015. There is no set-aside designation associated with this contract award.</p>

<p>This is a firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Sequoia Research Products LTD, a foreign-owned for-profit organization, for a study on drug repositioning. The contract has a ceiling value of $124,852.00 and an ultimate completion date of October 17, 2015. The contract is not set aside for any specific type of business. No further details about a larger contract vehicle are provided.</p>

This is a $91,396 firm fixed-price purchase order issued by the Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (De), for the ratification of Phoenix Quantum licenses in fiscal year 2017. Certara is a technology-enabled drug development and drug safety consultancy that specializes in biosimulation and has received multiple federal contracts from the Department of Health and Human Services, including the FDA, National Institutes of Health, and Centers for...

<p>This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to a small business vendor named Young, KIM R. The contract has a total ceiling value of $98,550.00 and a completion date of July 16, 2018. The contract was set aside for total small business participation. No details on the specific products or services being delivered were provided in the information given.</p>

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to F-D-C Reports Inc. for a site license to FDC Reports and Inteleos. The contract has a total ceiling value of $138,200.00 and was awarded on March 20, 2008, with a performance period ending on December 31, 2008. The contract is not designated as a set-aside. The award information does not indicate any subcontractors or a larger contract vehicle associated with this purchase order.

The Department of Health and Human Services, Food and Drug Administration awarded a fixed-price purchase order contract to Certara USA Inc., doing business as Tripos (De), for an annual Phoenix Quantum software subscription. The contract, with a potential value of $216,547.78, provides the FDA's Office of Clinical Pharmacology with the necessary modeling and simulation tools to analyze and verify sponsor submissions, including Investigational New Drug, New Drug, Biologics Licensing, and...

This is a $81,597.59 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Government Acquisitions Inc., a certified Historically Underutilized Business Zone (HUBZone) small business. The contract is for the delivery of PHOENIX QUANTUM SOFTWARE, with a performance period ending on July 11, 2029. The contract was awarded on an unrestricted basis, without a set-aside designation. Government Acquisitions Inc. is a for-profit Subchapter...

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>